Cargando…

Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab

Detalles Bibliográficos
Autores principales: Husein-ElAhmed, Husein, Molina-Leyva, Alejandro, Garrido-TorresPuchol, Valeriano, Ruiz-Carrascosa, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074921/
https://www.ncbi.nlm.nih.gov/pubmed/24413873
http://dx.doi.org/10.5144/0256-4947.2013.632
_version_ 1783344510200184832
author Husein-ElAhmed, Husein
Molina-Leyva, Alejandro
Garrido-TorresPuchol, Valeriano
Ruiz-Carrascosa, Jose
author_facet Husein-ElAhmed, Husein
Molina-Leyva, Alejandro
Garrido-TorresPuchol, Valeriano
Ruiz-Carrascosa, Jose
author_sort Husein-ElAhmed, Husein
collection PubMed
description
format Online
Article
Text
id pubmed-6074921
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher King Faisal Specialist Hospital and Research Centre
record_format MEDLINE/PubMed
spelling pubmed-60749212018-09-21 Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab Husein-ElAhmed, Husein Molina-Leyva, Alejandro Garrido-TorresPuchol, Valeriano Ruiz-Carrascosa, Jose Ann Saudi Med Letters King Faisal Specialist Hospital and Research Centre 2013 /pmc/articles/PMC6074921/ /pubmed/24413873 http://dx.doi.org/10.5144/0256-4947.2013.632 Text en Copyright © 2013, Annals of Saudi Medicine This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Letters
Husein-ElAhmed, Husein
Molina-Leyva, Alejandro
Garrido-TorresPuchol, Valeriano
Ruiz-Carrascosa, Jose
Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
title Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
title_full Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
title_fullStr Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
title_full_unstemmed Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
title_short Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
title_sort recalcitrant psoriasis responding to new bilogic drug: ustekinumab
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074921/
https://www.ncbi.nlm.nih.gov/pubmed/24413873
http://dx.doi.org/10.5144/0256-4947.2013.632
work_keys_str_mv AT huseinelahmedhusein recalcitrantpsoriasisrespondingtonewbilogicdrugustekinumab
AT molinaleyvaalejandro recalcitrantpsoriasisrespondingtonewbilogicdrugustekinumab
AT garridotorrespucholvaleriano recalcitrantpsoriasisrespondingtonewbilogicdrugustekinumab
AT ruizcarrascosajose recalcitrantpsoriasisrespondingtonewbilogicdrugustekinumab